MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 2 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $498,000 | -40.6% | 16,384 | -49.3% | 0.00% | -100.0% |
| Q1 2022 | $839,000 | -35.6% | 32,316 | -49.4% | 0.00% | 0.0% |
| Q4 2021 | $1,303,000 | -77.8% | 63,865 | -79.0% | 0.00% | -80.0% |
| Q3 2021 | $5,857,000 | -11.6% | 304,397 | +1.9% | 0.01% | -16.7% |
| Q2 2021 | $6,622,000 | -5.2% | 298,586 | +12.2% | 0.01% | -14.3% |
| Q1 2021 | $6,987,000 | +935.1% | 266,188 | +637.4% | 0.01% | +600.0% |
| Q4 2020 | $675,000 | -15.9% | 36,100 | -23.7% | 0.00% | 0.0% |
| Q3 2020 | $803,000 | -60.3% | 47,286 | -45.5% | 0.00% | -50.0% |
| Q2 2020 | $2,022,000 | +942.3% | 86,822 | +762.6% | 0.00% | – |
| Q3 2016 | $194,000 | -1.0% | 10,065 | 0.0% | 0.00% | – |
| Q2 2016 | $196,000 | -31.0% | 10,065 | -27.0% | 0.00% | – |
| Q1 2016 | $284,000 | – | 13,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |